Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan, PBSC, IL-2, GM-CSF, and Interferon Alfa in CML
NCT00005948Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2000
- Primary completion
- Oct 2001
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, aldesleukin, sargramostim, interferon alfa in chronic myelogenous leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started Jan 2000; status: completed.
02
Drugs
busulfanaldesleukinsargramostiminterferon alfa
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00005948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005948.